Skip to main content
SpringerLink
Log in

Synchronous colon carcinomas: Molecular-genetic evidence for multicentricity

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The synchronous presentation of multiple colonic adenocarcinomas is an unusual, but well-recognized event accounting for ∼2–11% of these neoplasms. Synchronous tumors may have a different biology and prognosis than solitary tumors. Evidence based on measurement of DNA ploidy suggests that a significant percentage of synchronous tumors have a common clonal origin, probably resulting from translumenal metastasis.

Methods: Fifteen synchronous colorectal cancers (30 tumors) were examined for histologic differences as well as genetic mutations. p53 gene abnormalities were detected by polymerase chain reaction (PCR) followed by single-strand conformation polymorphism analysis. Ki-ras mutations were detected by PCR followed by oligonucleotide-specific hybridization.

Results: p53 gene mutations were detected in 12 of 30 tumors. In only one case was the same p53 mutation present in both tumors from one patient. Similarly, Ki-ras mutations were observed in 9 of 30 tumors. Concordant Ki-ras mutations were observed in only one case, which was also concordant for p53 mutation.

Conclusion: Because p53 and Ki-ras mutations tend to occur fairly early in tumor development, it seems likely that cases discordant for p53 and Ki-ras mutations represent independently developing tumor foci. Taken together, these findings strongly suggest that the great majority of synchronous colonic adenocarcinomas arise as independent neoplasms and their worsened prognosis is not a result of unusually early metastatic spread.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adloff M, Arnaud JP, Bergamaschi R, Schloegel M. Synchronous carcinoma of the colon and rectum: prognostic and therapeutic implications.Am J Surg 1989;157:299–302.

    Article  CAS  PubMed  Google Scholar 

  2. Schwartz D, Banner BF, Roseman DL, Coon JS. Origin of multiple primary colon carcinomas: a retrospective flow cytometric study.Cancer 1986;58:2082–8.

    CAS  PubMed  Google Scholar 

  3. Smit VTHBM, Fleuren GJ, van Houwelingen JC, Zegveld ST, Kuipers-Dijkshoorn NJ, Cornelisse CJ. Flow cytometric DNA-ploidy analysis of synchronously occurring multiple malignant tumors of the female genital tract.Cancer 1990;66:1843–9.

    CAS  PubMed  Google Scholar 

  4. Chen P, Hurst T, Khoo SK. Detection of somatic DNA alterations in ovarian cancer by DNA fingerprint analysis.Cancer 1990;67:1551–5.

    Google Scholar 

  5. Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BAJ, Humphrey P, et al. Clonal origin of epithelial ovarian carcinoma: analysis of loss of heterozygosity, p53 mutation, and X-chromosome inactivation.J Natl Cancer Inst 1992;84:1793–8.

    CAS  PubMed  Google Scholar 

  6. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer.N Engl J Med 1992;326:737–40.

    CAS  PubMed  Google Scholar 

  7. Noguchi M, Maezawa N, Nakanishi Y, Matsuno Y, Shimosato Y, Hirohashi S. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas.Diagn Mol Pathol 1993;2:29–35.

    CAS  PubMed  Google Scholar 

  8. Dukes CE. The classification of cancer of the rectum.J Pathol Bacteriol 1932;35:322.

    Article  Google Scholar 

  9. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, et al. Overexpression and mutation of p53 in epithelial ovarian cancer.Cancer Res 1991;51:2979–84.

    CAS  PubMed  Google Scholar 

  10. Murakami Y, Hayashi K, Sekiya T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.Cancer Res 1991;51:3356–61.

    CAS  PubMed  Google Scholar 

  11. Orita M, Iwahana H, Knazawa H, Hayashi K, Sekey T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.Proc Natl Acad Sci USA 1989;86:2766–70.

    CAS  PubMed  Google Scholar 

  12. Yandell DW, Dryja TP. 1989. Detection of DNA sequence polymorphisms by enzymatic amplification and genomic sequencing.Am J Hum Genet 1989;45:547–55.

    CAS  PubMed  Google Scholar 

  13. Slebos TJC, Boerrigter L, Evers SG, Wisman P, Mooi W, Rodenhuis S. A rapid and simple procedure for the routine detection of ras point mutations in formalin fixed, paraffinembedded tissues.Diagn Molec Pathol 1992;1:136–41.

    CAS  Google Scholar 

  14. Slater G, Aufses AH Jr, Szporn A. Synchronous carcinoma of the colon and rectum.Surg Gynecol Obstet 1990;171:283–7.

    CAS  PubMed  Google Scholar 

  15. Finan P, Ritchie JK, Hawley PR. Synchronous and early metachronous carcinomas of the colon and rectum.Br J Surg 1987;74:945–7.

    CAS  PubMed  Google Scholar 

  16. Magnusson I, Falkmer UG, Nilsson R. Multiple primary colorectal adenocarcinomas: cytometric DNA ploidy patterns and histopathologic features.Dis Colon Rectum 1991;34:810–5.

    Article  CAS  PubMed  Google Scholar 

  17. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene.Nature 1991;351:453–6.

    Article  CAS  PubMed  Google Scholar 

  18. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers.Science 1991;253:49–53.

    CAS  PubMed  Google Scholar 

  19. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, et al. Mutations in the p53 gene occur in diverse human tumor types.Nature 1989;342:705–8.

    Article  CAS  PubMed  Google Scholar 

  20. Uchino S, Noguchi M, Ochiai A. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer.Int J Cancer 1993;54:759–64.

    CAS  PubMed  Google Scholar 

  21. Uchino S, Noguchi M, Hirota T, Itabashi M, Saito T, Kobayashi M, Hirohashi S. High incidence of nuclear accumulation of p53 protein in gastric cancer.Jpn J Clin Oncol 1992;22:225–31.

    CAS  PubMed  Google Scholar 

  22. Lowe SW, Ruley HE, Jacks T. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.Cell 1993;74:957–67.

    Article  CAS  PubMed  Google Scholar 

  23. Dive C, Hickman J. Drug target interactions: only the first step in the commitment to a programmed cell death?Br J Cancer 1991;64:192–6.

    CAS  PubMed  Google Scholar 

  24. Bajorin D, Sarkis A, Reuter V, Netto G, Cordon-Cardo C, Zhang ZF, Herr H, et al. Invasive bladder cancer treated with neoadjuvant MVAC: The relationship of p53 nuclear overexpression with survival.Proc ASCO 1994;13:714.

    Google Scholar 

  25. Wattel E, Preudomme C, Gecquet B, Vandrumbeke M, Quesnel B, Dervite I, Morel P, et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies.Blood 1994;84:3148–57.

    CAS  PubMed  Google Scholar 

  26. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher D, Housman DE, et al. p53 status and the efficacy of cancer therapy in vivo.Science 1994;266:807–10.

    CAS  PubMed  Google Scholar 

  27. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers.Science 1991;253:49–53.

    CAS  PubMed  Google Scholar 

  28. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B. Oncogenic forms of p53 inhibit p53-regulated gene expression.Science 1992;256:827–30.

    CAS  PubMed  Google Scholar 

  29. Okamoto A, Sameshima Y, Yokoyama S, Terashima Y, Sugimura T, Terada M, Yokota J. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.Cancer Res 1991;51:5171–6.

    CAS  PubMed  Google Scholar 

  30. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors.Am J Pathol 1991;140:145–53.

    Google Scholar 

  31. Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, et al. Overexpression and mutation of p53 in epithelial ovarian cancer.Cancer Res 1991;51:2979–84.

    CAS  PubMed  Google Scholar 

  32. Eccles DM, Brett L, Lessells A, Gruder L, Lane D, Steel CM, Leongard RC. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.Br J Cancer 1992;65:40–4.

    CAS  PubMed  Google Scholar 

  33. Matsushima AY, Cesarman E, Chadburn A, Knowles DM. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.Am J Pathol 1994;144:573–83.

    CAS  PubMed  Google Scholar 

  34. Elenitoba-Johnson K, Medeiros LJ, Khorsand J, King TC. Role of p53 mutations in Hodgkin's disease [Abstract].Mod Path 1995;8:109A.

    Google Scholar 

  35. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE, Taylor GR, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer.Gastroenterology 1993;104:57–64.

    CAS  PubMed  Google Scholar 

  36. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence ofras gene mutations in human colorectal cancer.Nature 1987;327:293–7.

    Article  CAS  PubMed  Google Scholar 

  37. Lothe RA, Fossli T, Danielsen HE, Stenwig AE, Nesland JM, Gallie B, Borresen AL. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.J Natl Cancer Inst 1992;84:1100–8.

    CAS  PubMed  Google Scholar 

  38. Stanbridge EJ. Identifying tumor suppressor genes in human colorectal cancer.Science 1990;247:12–3.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Surgery, Brown University School of Medicine, Providence, Rhode Island, USA

    R. James Koness MD, Steven Schechter MD, Susan F. McLean MD & Harold J. Wanebo MD

  2. the Department of Surgery, Brown University School of Medicine, Providence, Rhode Island, USA

    Thomas C. King MD, PhD

Authors
  1. R. James Koness MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas C. King MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Schechter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan F. McLean MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Christopher Lodowsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Harold J. Wanebo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koness, R.J., King, T.C., Schechter, S. et al. Synchronous colon carcinomas: Molecular-genetic evidence for multicentricity. Annals of Surgical Oncology 3, 136–143 (1996). https://doi.org/10.1007/BF02305792

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02305792

Key Words

Search

Navigation